1. Home
  2. AMSC vs NTLA Comparison

AMSC vs NTLA Comparison

Compare AMSC & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

HOLD

Current Price

$28.79

Market Cap

1.5B

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$12.85

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSC
NTLA
Founded
1987
2014
Country
United States
United States
Employees
400
N/A
Industry
Metal Fabrications
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2012
2016

Fundamental Metrics

Financial Performance
Metric
AMSC
NTLA
Price
$28.79
$12.85
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$52.00
$20.45
AVG Volume (30 Days)
685.0K
3.6M
Earning Date
02-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
143.24
27.43
EPS
3.01
N/A
Revenue
$900,000.00
$67,671,000.00
Revenue This Year
$34.98
N/A
Revenue Next Year
$21.38
$62.75
P/E Ratio
$10.18
N/A
Revenue Growth
N/A
16.92
52 Week Low
$13.98
$5.90
52 Week High
$70.49
$28.24

Technical Indicators

Market Signals
Indicator
AMSC
NTLA
Relative Strength Index (RSI) 42.43 47.56
Support Level $25.84 $12.55
Resistance Level $34.14 $14.61
Average True Range (ATR) 1.69 0.73
MACD -0.14 -0.11
Stochastic Oscillator 33.91 13.39

Price Performance

Historical Comparison
AMSC
NTLA

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: